Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Melanoma

  Free Subscription


3 Ann Surg Oncol
1 BMC Cancer
1 BMC Ophthalmol
1 Br J Dermatol
1 Clin Cancer Res
1 Int J Cancer
1 J Am Acad Dermatol
1 J Surg Oncol
1 Lancet Oncol
2 Melanoma Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg Oncol

  1. LOWE MC, Delman KA
    A Call to Arms: Surgeons Must Play an Important and Early Role in the Management of Patients with Advanced Melanoma.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07648.
    PubMed     Text format    

  2. OLLILA DW, Meyers MO
    Time may Heal All Wounds, but While It Does, Melanoma Marches on.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07674.
    PubMed     Text format    

  3. KATSARELIAS D, Isaksson K, Olofsson Bagge R
    ASO Author Reflections: Effects of the Updated AJCC Classification for Patients with Stage III Melanoma.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07765.
    PubMed     Text format    

    BMC Cancer

  4. DOMA V, Karpati S, Raso E, Barbai T, et al
    Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma.
    BMC Cancer. 2019;19:853.
    PubMed     Text format     Abstract available

    BMC Ophthalmol

  5. JAARSMA-COES MG, Ferreira TA, Luyten GPM, Beenakker JWM, et al
    Reaction on "Ocular ultrasound versus MRI in the detection of extrascleral extension in a patient with choroidal melanoma".
    BMC Ophthalmol. 2019;19:193.
    PubMed     Text format     Abstract available

    Br J Dermatol

  6. CHAN MP
    Refining the ever-evolving molecular landscape of spitzoid melanocytic neoplasms.
    Br J Dermatol. 2019;180:262.
    PubMed     Text format    

    Clin Cancer Res

  7. JIANG H, Shin DH, Nguyen TT, Fueyo J, et al
    Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas.
    Clin Cancer Res. 2019 Aug 27. pii: 1078-0432.CCR-19-0405.
    PubMed     Text format     Abstract available

    Int J Cancer

  8. BRUSCO I, Li Puma S, Chiepe KB, da Silva Brum E, et al
    Dacarbazine alone or associated with melanoma-bearing cancer pain model induces painful hypersensitivity by TRPA1 activation in mice.
    Int J Cancer. 2019 Aug 28. doi: 10.1002/ijc.32648.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  9. PUYANA C, Kim S, Wilson C, Tsoukas MM, et al
    Lymph Node Negative Melanoma Survival; an Analysis of 51,846 Cases.
    J Am Acad Dermatol. 2019 Aug 23. pii: S0190-9622(19)32649.
    PubMed     Text format    

    J Surg Oncol

  10. DECKERS EA, Wevers KP, Muller Kobold AC, Damude S, et al
    S-100B as an extra selection tool for FDG PET/CT scanning in follow-up of AJCC stage III melanoma patients.
    J Surg Oncol. 2019 Aug 29. doi: 10.1002/jso.25682.
    PubMed     Text format     Abstract available


  11. ABBASI J
    Detecting Circulating Tumor Cells Through the Skin.
    JAMA. 2019;322:495.
    PubMed     Text format    

    Lancet Oncol

  12. DAS M
    Non-radioactive imaging for SLN detection in melanoma.
    Lancet Oncol. 2019 Aug 22. pii: S1470-2045(19)30540.
    PubMed     Text format    

    Melanoma Res

  13. MORENO-ARRONES OM, Zegeer J, Gerbo M, Manrique-Silva E, et al
    Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.
    Melanoma Res. 2019 Aug 28. doi: 10.1097/CMR.0000000000000638.
    PubMed     Text format     Abstract available

  14. JOHANSSON PA, Nathan V, Bourke LM, Palmer JM, et al
    Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
    Melanoma Res. 2019;29:483-490.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.